Enanta Pharmaceuticals (ENTA) Enterprise Value (2012 - 2026)
Enanta Pharmaceuticals (ENTA) posted Enterprise Value of -$163.8 million for Q1 2026, up 11.88% on a QoQ basis from -$185.8 million in Q4 2025, and up 15.31% year-over-year from -$142.0 million in Q1 2025.
Enanta Pharmaceuticals (ENTA) Enterprise Value (2012 - 2026) Analysis & Trends
Enanta Pharmaceuticals' Enterprise Value history runs 15 years deep, the most recent figure standing at -$163.8 million for Q1 2026.
- Quarterly Enterprise Value rose 15.31% year-over-year to -$163.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$163.8 million (up 15.31% YoY) and the FY2025 annual result came in at -$188.9 million, down 399.1% from the prior year.
- Enterprise Value was -$163.8 million for Q1 2026 at Enanta Pharmaceuticals, up from -$185.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$37.8 million in Q3 2024 and bottomed at -$386.6 million in Q2 2023.
- A 5-year average of -$210.5 million and a median of -$214.5 million in 2022 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 80.52% in 2025, while the deepest fall reached 399.1% in 2025.
- Enanta Pharmaceuticals' Enterprise Value stood at -$214.5 million in 2022, then tumbled by 57.2% to -$337.2 million in 2023, then soared by 35.73% to -$216.7 million in 2024, then climbed by 14.23% to -$185.8 million in 2025, then advanced by 11.88% to -$163.8 million in 2026.
- Business Quant data shows ENTA's Enterprise Value at -$163.8 million in Q1 2026, -$185.8 million in Q4 2025, and -$188.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Enanta Pharmaceuticals | 376.07 Mn | 212.29 Mn | - | -163.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -163.77 Mn |
| Dec 31, 2025 | -185.85 Mn |
| Sep 30, 2025 | -188.86 Mn |
| Jun 30, 2025 | -44.81 Mn |
| Mar 31, 2025 | -193.38 Mn |
| Dec 31, 2024 | -216.69 Mn |
| Sep 30, 2024 | -37.84 Mn |
| Jun 30, 2024 | -230.09 Mn |
| Mar 31, 2024 | -300.31 Mn |
| Dec 31, 2023 | -337.15 Mn |
| Sep 30, 2023 | -85.39 Mn |
| Jun 30, 2023 | -386.59 Mn |
| Mar 31, 2023 | -210.08 Mn |
| Dec 31, 2022 | -214.47 Mn |
| Sep 30, 2022 | -249.23 Mn |
| Jun 30, 2022 | -253.29 Mn |
| Mar 31, 2022 | -280.33 Mn |
| Dec 31, 2021 | -259.05 Mn |
| Sep 30, 2021 | -244.00 Mn |
| Jun 30, 2021 | -256.82 Mn |